Evidence map›Paper›PMID 39117164›Full record

ArticleInternational journal of radiation oncology, biology, physics2025

Autodelineation of Treatment Target Volume for Radiation Therapy Using Large Language Model-Aided Multimodal Learning.

Praveenbalaji Rajendran, Yizheng Chen, Liang Qiu, Thomas Niedermayr, Wu Liu, Mark Buyyounouski, Hilary Bagshaw, Bin Han, Yong Yang, Nataliya Kovalchuk and 4 more

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical Applications of Multimodal Artificial Intelligence in Otolaryngology: A State-of-the-Art Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Systematic review of artificial intelligence in brachytherapy.Journal of contemporary brachytherapy · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Praveenbalaji RajendranDepartment of Radiation Oncology, Stanford University, Stanford, California.
Yizheng ChenDepartment of Radiation Oncology, Stanford University, Stanford, California.
Liang QiuDepartment of Radiation Oncology, Stanford University, Stanford, California.
Thomas NiedermayrDepartment of Radiation Oncology, Stanford University, Stanford, California.
Wu LiuDepartment of Radiation Oncology, Stanford University, Stanford, California.
Mark BuyyounouskiDepartment of Radiation Oncology, Stanford University, Stanford, California.
Hilary BagshawDepartment of Radiation Oncology, Stanford University, Stanford, California.
Bin HanDepartment of Radiation Oncology, Stanford University, Stanford, California.
Yong YangDepartment of Radiation Oncology, Stanford University, Stanford, California.
Nataliya KovalchukDepartment of Radiation Oncology, Stanford University, Stanford, California.
Xuejun GuDepartment of Radiation Oncology, Stanford University, Stanford, California.
Steven HancockDepartment of Radiation Oncology, Stanford University, Stanford, California.
Lei XingDepartment of Radiation Oncology, Stanford University, Stanford, California.
Xianjin DaiDepartment of Radiation Oncology, Stanford University, Stanford, California. Electronic address: xjdai@stanford.edu.

Funding

Dual Modality X-ray Luminescence CT for in vivo Cancer ImagingR01CA227713 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2019 to 2023
$2.9M
An artificial intelligence-driven distributed stereotactic radiosurgery strategy for multiple brain metastases managementR01CA235723 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GU, XUEJUN, LU, WEIGUO · 2019 to 2024
$2.9M
Radioluminescence dosimetry solution for precision radiation therapyR01CA223667 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2018 to 2022
$2.4M
DASSIM-RT and Compressed Sensing-Based Inverse PlanningR01CA176553 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2014 to 2018
$2.4M
Leveraging deep learning for markerless motion management in radiation therapyR01CA256890 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2021 to 2025
$2.1M
NCI NIH HHS R01 CA176553NCI NIH HHS R01 CA223667NCI NIH HHS R01 CA227713NCI NIH HHS R01 CA235723NCI NIH HHS R01 CA256890
6 · The paper itself

Abstract

purposeArtificial intelligence-aided methods have made significant progress in the auto-delineation of normal tissues. However, these approaches struggle with the auto-contouring of radiation therapy target volume. Our goal was to model the delineation of target volume as a clinical decision-making problem, resolved by leveraging large language model-aided multimodal learning approaches. METHODS AND MATERIALS: A vision-language model, termed Medformer, has been developed, employing the hierarchical vision transformer as its backbone and incorporating large language models to extract text-rich features. The contextually embedded linguistic features are seamlessly integrated into visual features for language-aware visual encoding through the visual language attention module. Metrics, including Dice similarity coefficient (DSC), intersection over union (IOU), and 95th percentile Hausdorff distance (HD95), were used to quantitatively evaluate the performance of our model. The evaluation was conducted on an in-house prostate cancer data set and a public oropharyngeal carcinoma data set, totaling 668 subjects.

resultsOur Medformer achieved a DSC of 0.81 ± 0.10 versus 0.72 ± 0.10, IOU of 0.73 ± 0.12 versus 0.65 ± 0.09, and HD95 of 9.86 ± 9.77 mm versus 19.13 ± 12.96 mm for delineation of gross tumor volume on the prostate cancer dataset. Similarly, on the oropharyngeal carcinoma dataset, it achieved a DSC of 0.77 ± 0.11 versus 0.72 ± 0.09, IOU of 0.70 ± 0.09 versus 0.65 ± 0.07, and HD95 of 7.52 ± 4.8 mm versus 13.63 ± 7.13 mm, representing significant improvements (P < 0.05). For delineating the clinical target volume, Medformer achieved a DSC of 0.91 ± 0.04, IOU of 0.85 ± 0.05, and HD95 of 2.98 ± 1.60 mm, comparable with other state-of-the-art algorithms.

conclusionsAuto-delineation of the treatment target based on multimodal learning outperforms conventional approaches that rely purely on visual features. Our method could be adopted into routine practice to rapidly contour clinical target volume/gross tumor volume.

Indexed as

Prostatic NeoplasmsRadiotherapy Planning, Computer-AssistedAlgorithmsArtificial IntelligenceHumansMaleOropharyngeal NeoplasmsTumor Burden

Identifiers

PMID39117164
PMCPMC13041240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.